YUH-27579-13093
3 vaccinations
7 coded responses
39 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 974 / OR
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Registered in v-safe
-
2021-03-21
Dose 1 — Pfizer-BioNTech
- 2021-03-21
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
-
2021-04-11
Dose 2 — Pfizer-BioNTech
-
2021-04-11
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Vomiting, DiarrheaAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
-
2021-07-12
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had a cold.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-10
-
2021-10-28
Dose 3 — Pfizer-BioNTech
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-31
Survey response — days 1–6 daily, dose 3MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Site: Pain · Chills, Headache, Nausea, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: The above were related to severe acid reflux (I have a diagnosed condition for this).MedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Report sent to call center — days 1–6 daily, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I want to state that the above are related to my GERD having a flare-upMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Survey response — days 1–6 daily, dose 3MedDRA: Gastrooesophageal reflux disease — Feeling: Poor · Fatigue or tiredness, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: The symptoms I am experiencing are due to an chronic GERD diagnosis, not my booster.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
-
2021-11-04
Survey response — day 7, dose 3MedDRA: Pre-existing disease, SARS-CoV-2 test negative — Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: All of the above are due to GERD and other health conditions I have that are chronic, I have had a negative COVID test.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Report sent to call center — day 7, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-05
- 2021-11-11
- 2021-11-18
- 2021-11-27
-
2021-12-02
Survey response — day 35, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Have a cold, have been tested for COVID twice while exhibiting symptoms and tests were negative. I have been working from home.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-11
- 2022-01-27
- 2022-04-28
-
2022-10-29
Survey response — 12 months, dose 3MedDRA: Fatigue — Feeling: FairFree text: Chronic fatigue diagnosisMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-31 | Unsuccessful | |
| 2021-11-04 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: I had a cold.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): The above were related to severe acid reflux (I have a diagnosed condition for this).
Systemic reaction (other): I want to state that the above are related to my GERD having a flare-up
Systemic reaction (other): The symptoms I am experiencing are due to an chronic GERD diagnosis, not my booster.
Release 10 — day 7, dose 3
Systemic reaction (other): All of the above are due to GERD and other health conditions I have that are chronic, I have had a negative COVID test.
Release 10 — day 35, dose 3
Symptoms: Have a cold, have been tested for COVID twice while exhibiting symptoms and tests were negative. I have been working from home.
Release 12 — 12 months, dose 3
Symptoms: Chronic fatigue diagnosis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Gastrooesophageal reflux disease | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release